Get ready to mark your calendars because the much anticipated third quarter financial results of INmune Bio (NASDAQ: INMB) are set to be unveiled on Thursday 31st October 2024. Investors and market watchers will have the chance to dive into the company's financial performance as the announcement is scheduled after market close.
Wall Street financial analysts are foreseeing that the organization is likely to announce an estimated per share $0.50 loss for the quarter.
During the equivalent quarter of the preceding year, the company's financial report highlighted a per-share loss of $0.48. This significant amount was the outcome of the company's total revenue, which reached an impressive $0.04 million during that particular timeframe.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $0.02 million. Additionally, they forecast the earnings per share to hit loss of $2.16 for the fiscal year.
The business has scheduled a conference call on 31st October 2024 at 04:30 PM eastern time to discuss Q3 financial results.
The previous trading day saw INmune Bio (INMB) shares trading between $6.15 and $6.66, besides a volume of 534.00 thousand shares. The stock closed Tuesday's regular trading session at $6.30, reflecting 2.27 percent advance.
